Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ABL Europe
Illkirch-Graffenstaden, Grand Est, France
- Ownership
- Private
- Employees
- ~271
- Development stage
- Other
01
Overview
ABL Europe is a specialist GMP-certified CDMO in France (Illkirch-Graffenstaden and Lyon) for viral vector manufacturing, supporting gene therapy, oncolytic virus, and vaccine clinical/commercial supply. Acquired by Oxford Biomedica in January 2024, making it part of one of the largest global cell and gene therapy CDMOs, with expanded capabilities in multiple viral vector types. It offers manufacturing for all clinical stages and is an expert in both adherent and suspension systems, able to support projects up to and including BSL3 containment. Major focus areas are immunotherapy, oncology, infectious diseases, and gene therapy.
- Modalities
- Viral vectorGene therapyOncolytic virus therapyVaccine
- Industry
- Contract Manufacturing Organization
02
Partnerships
Oxford Biomedica (acquirer)Institut Mérieux (previous parent and current shareholder of Oxford Biomedica)
Beyond the preview
Go deeper on ABL Europe.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ABL Europe.